Johnston, Adam Comment on Effects of Tax Law Change on Health Fraud Settlement Costs
23 February 2018
Partners Pam Johnston and Fred Adam are quoted in a BNA Health Care Daily Report article, “Tax Law Change May Raise Health Fraud Settlement Costs,” about the possible effects of a change in the tax rules governing the deduction of health care fraud settlement amounts.
A provision of the new tax reform act, signed into law on Dec. 22, requires a settling agency, like the Department of Justice, to state what portion of a False Claim Act settlement can be deducted as a business expense because it qualifies as restitution. The tax provision also eliminates certain types of previously deductible expenses related to FCA settlements, like government investigation expenses and interest.
Johnston said the new deductibility rules will “materially affect negotiations with the DOJ” over FCA settlements because limiting the deduction of the settlement amount could make the settlement less attractive.
Adam said the new provision “increases costs for both sides, for taxpayers and for the government.”
Subscription required to read.
A provision of the new tax reform act, signed into law on Dec. 22, requires a settling agency, like the Department of Justice, to state what portion of a False Claim Act settlement can be deducted as a business expense because it qualifies as restitution. The tax provision also eliminates certain types of previously deductible expenses related to FCA settlements, like government investigation expenses and interest.
Johnston said the new deductibility rules will “materially affect negotiations with the DOJ” over FCA settlements because limiting the deduction of the settlement amount could make the settlement less attractive.
Adam said the new provision “increases costs for both sides, for taxpayers and for the government.”
Subscription required to read.
People
Related News
17 May 2024
In the News
Foley’s IP Litigation Win Receives Shout Out in AmLaw Litigation Daily, Highlighted Across Legal Press
Foley & Lardner LLP’s recent delivery of summary judgment in a trademark and trade dress infringement case received coverage across legal press
14 May 2024
In the News
Thomas Ferrante on Interstate Health Policy Conflicts – ‘I’d definitely recommend paying attention’
Foley & Lardner LLP partner Thomas Ferrante offered insight on how a patchwork of shifting state legislation on health care issues are stretching constitutional limits
14 May 2024
In the News
Christopher Swift on China Biotech Crackdown – ‘There’ll be more self-initiated serious investigations into these kinds of transactions’
Foley & Lardner LLP partner Christopher Swift assessed the potential impact of the BIOSECURE Act – aimed at banning trade with major Chinese biotechnology firms